Omar Y. Mian

Omar Y. Mian

Radiation Oncology

9500 Euclid Avenue
Cleveland, OH 44195

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.

Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management Implications.

Journal: European urology

Published: February 20, 2026

Reply to: Toward Clinical Readiness: Critical Reflections on PATHOMIQ_PRAD and Artificial Intelligence Histologic Classifiers in Prostate Cancer.

Reply to: Toward Clinical Readiness: Critical Reflections on PATHOMIQ_PRAD and Artificial Intelligence Histologic Classifiers in Prostate Cancer.

Journal: JCO clinical cancer informatics

Published: November 26, 2025

Split-Dose FLASH Irradiation to Investigate the Clinical Feasibility of Multifield Treatments: The Effect of Split Dose and Dose Rate on FLASH.

Split-Dose FLASH Irradiation to Investigate the Clinical Feasibility of Multifield Treatments: The Effect of Split Dose and Dose Rate on FLASH.

Journal: International journal of radiation oncology, biology, physics

Published: September 09, 2025

AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma.

AI-informed computational pathology classifier predicts outcomes across treatment modalities in muscle-invasive urothelial carcinoma.

Journal: Cancer letters

Published: July 09, 2025

Artificial Intelligence-Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy.

Artificial Intelligence-Based Digital Histologic Classifier for Prostate Cancer Risk Stratification: Independent Blinded Validation in Patients Treated With Radical Prostatectomy.

Journal: JCO clinical cancer informatics

Published: June 18, 2025

Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing Therapy.

Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing Therapy.

Journal: Clinical genitourinary cancer

Published: May 13, 2025

Different Patterns of Oral Mucositis and Microbiota Injury After Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Different Patterns of Oral Mucositis and Microbiota Injury After Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Journal: Advances in radiation oncology

Published: March 20, 2025

Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure.

Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure.

Journal: Pediatric blood & cancer

Published: January 27, 2025

Patterns of Recurrence Following Radiation and ADT for Pathologic Lymph Node-Positive Prostate Cancer: A Multi-institutional Study.

Patterns of Recurrence Following Radiation and ADT for Pathologic Lymph Node-Positive Prostate Cancer: A Multi-institutional Study.

Journal: Practical radiation oncology

Published: October 07, 2024

Patient-specific adaptive planning margin for whole bladder radiation therapy.

Patient-specific adaptive planning margin for whole bladder radiation therapy.

Journal: Journal of applied clinical medical physics

Published: September 17, 2024

NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.

NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 16, 2024

Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial.

Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: March 14, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026